Wedbush Securities Inc Nymox Pharmaceutical Corp Transaction History

Wedbush Securities Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$1.84 - $2.83 $35,144 - $54,053	-19,100 Closed	0 $0
Q3 2020 Oct 20, 2020	SELL	$2.3 - $3.66 $28,749 - $45,750	-12,500 Reduced 39.56%	19,100 $47,000
Q2 2020 Jul 16, 2020	SELL	$2.1 - $4.6 $4,830 - $10,580	-2,300 Reduced 6.78%	31,600 $112,000
Q1 2020 Apr 17, 2020	SELL	$1.69 - $3.88 $14,495 - $33,278	-8,577 Reduced 20.19%	33,900 $79,000
Q4 2019 Jan 16, 2020	SELL	$1.73 - $2.42 $34,985 - $48,939	-20,223 Reduced 32.25%	42,477 $93,000
Q3 2019 Oct 17, 2019	SELL	$1.41 - $2.12 $82,111 - $123,458	-58,235 Reduced 48.15%	62,700 $115,000
Q2 2019 Aug 01, 2019	BUY	$1.33 - $2.12 $9,576 - $15,264	7,200 Added 6.33%	120,935 $175,000
Q1 2019 Apr 17, 2019	SELL	$1.57 - $2.71 $49,298 - $85,094	-31,400 Reduced 21.64%	113,735 $224,000
Q4 2018 Jan 31, 2019	SELL	$1.31 - $2.53 $14,213 - $27,450	-10,850 Reduced 6.96%	145,135 $190,000
Q3 2018 Nov 13, 2018	SELL	$2.46 - $3.7 $157,053 - $236,219	-63,843 Reduced 29.04%	155,985 $384,000
Q2 2018 Aug 03, 2018	SELL	$3.12 - $4.33 $87,618 - $121,599	-28,083 Reduced 11.33%	219,828 $739,000
Q1 2018 May 01, 2018	SELL	$3.09 - $4.43 $90,431 - $129,648	-29,266 Reduced 10.56%	247,911 $1.05 Million
Q4 2017 Feb 09, 2018	BUY	$3.29 - $4.06 $57,525 - $70,989	17,485 Added 6.73%	277,177 $915,000
Q3 2017 Oct 31, 2017	BUY	$3.36 - $4.02 $872,565 - $1.04 Million	259,692	259,692 $992,000

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.